Barbara E. Bierer

14.9k total citations · 4 hit papers
244 papers, 11.2k citations indexed

About

Barbara E. Bierer is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Barbara E. Bierer has authored 244 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Immunology, 79 papers in Public Health, Environmental and Occupational Health and 61 papers in Molecular Biology. Recurrent topics in Barbara E. Bierer's work include Ethics in Clinical Research (54 papers), Immune Cell Function and Interaction (50 papers) and T-cell and B-cell Immunology (46 papers). Barbara E. Bierer is often cited by papers focused on Ethics in Clinical Research (54 papers), Immune Cell Function and Interaction (50 papers) and T-cell and B-cell Immunology (46 papers). Barbara E. Bierer collaborates with scholars based in United States, United Kingdom and Canada. Barbara E. Bierer's co-authors include Steven J. Burakoff, Jennifer S. Tirnauer, Víctor Calvo, Claude B. Klee, Jill E. Hutchcroft, William C. Hahn, Stuart L. Schreiber, Luke Gelinas, Daniel J. Price and Jeffrey Grove and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Barbara E. Bierer

233 papers receiving 10.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

1992 711 citations Barbara E. Bierer et al. profile →
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.

1990 585 citations Barbara E. Bierer et al. profile →
Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase

1992 583 citations Barbara E. Bierer et al. profile →
Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations

2017 301 citations Luke Gelinas, I. Glenn Cohen et al. The American Journal of Bioethics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Barbara E. Bierer	5.2k	4.0k	2.0k	1.2k	1.1k	244	11.2k
Laurie A. Davidson	6.5k 1.3×	5.3k 1.3×	2.3k 1.2×	498 0.4×	950 0.9×	169	14.2k
C. Glenn Begley	3.1k 0.6×	3.0k 0.8×	1.9k 0.9×	975 0.8×	591 0.5×	144	10.8k
John Cohen	7.2k 1.4×	5.0k 1.3×	1.5k 0.7×	676 0.6×	1.2k 1.1×	209	14.9k
Alan Bernstein	10.9k 2.1×	3.9k 1.0×	3.4k 1.7×	657 0.5×	2.3k 2.1×	219	19.4k
Bruce M. McManus	5.6k 1.1×	3.2k 0.8×	1.5k 0.7×	572 0.5×	674 0.6×	379	17.7k
Michael J. Kelley	4.6k 0.9×	2.0k 0.5×	3.3k 1.7×	482 0.4×	614 0.6×	354	13.0k
David L. Scott	4.5k 0.9×	2.7k 0.7×	1.2k 0.6×	515 0.4×	994 0.9×	419	19.9k
David E. Golan	7.4k 1.4×	2.0k 0.5×	638 0.3×	695 0.6×	1.2k 1.1×	144	13.3k
John B. Lowe	9.8k 1.9×	5.2k 1.3×	2.6k 1.3×	945 0.8×	1.5k 1.4×	293	18.8k
Emile E. Voest	7.3k 1.4×	1.9k 0.5×	8.5k 4.3×	938 0.8×	1.3k 1.2×	370	18.8k

Countries citing papers authored by Barbara E. Bierer

Since Specialization

Citations

This map shows the geographic impact of Barbara E. Bierer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara E. Bierer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara E. Bierer more than expected).

Fields of papers citing papers by Barbara E. Bierer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara E. Bierer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara E. Bierer. The network helps show where Barbara E. Bierer may publish in the future.

Co-authorship network of co-authors of Barbara E. Bierer

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara E. Bierer. A scholar is included among the top collaborators of Barbara E. Bierer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara E. Bierer. Barbara E. Bierer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joffe, Steven, Albert J. Allen, Elisa Koppelman, et al.. (2023). Establishing a global regulatory floor for children’s decisions about participation in clinical research. Pediatric Research. 94(2). 462–465. 1 indexed citations

Gelinas, Luke, et al.. (2023). Characterization of key information sections in informed consent forms posted on ClinicalTrials.gov. Journal of Clinical and Translational Science. 7(1). e185–e185. 3 indexed citations

Gelinas, Luke, et al.. (2023). Terms and conditions apply: an ethical analysis of mobile health user agreements in research. Journal of Law and the Biosciences. 10(2). lsad021–lsad021. 2 indexed citations

Marrie, Ruth Ann, Jeremy Chataway, Barbara E. Bierer, et al.. (2023). Enhancing diversity of clinical trial populations in multiple sclerosis. Multiple Sclerosis Journal. 29(9). 1174–1185. 19 indexed citations

Gelinas, Luke, David H. Strauss, Ying Chen, et al.. (2022). Protecting the Vulnerable and Including the Under-Represented: IRB Practices and Attitudes. Journal of Empirical Research on Human Research Ethics. 18(1-2). 58–68. 3 indexed citations

Friesen, Phoebe, et al.. (2022). IRBs and the Protection-Inclusion Dilemma: Finding a Balance. The American Journal of Bioethics. 23(6). 75–88. 27 indexed citations

Sonstein, Stephen A., et al.. (2022). Incorporating Competencies Related to Project Management into the Joint Taskforce Core Competency Framework for Clinical Research Professionals. Therapeutic Innovation & Regulatory Science. 56(2). 206–211. 6 indexed citations

White, Sarah, et al.. (2022). Developing a consensus-driven, plain-language clinical research glossary for study participants and the clinical research community. Journal of Clinical and Translational Science. 6(1). e50–e50. 1 indexed citations

Bierer, Barbara E., et al.. (2022). Advancing the inclusion of underrepresented women in clinical research. Cell Reports Medicine. 3(4). 100553–100553. 73 indexed citations

10.

Plosky, Willyanne DeCormier, Ari Ne’eman, Benjamin C. Silverman, et al.. (2022). Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification. Health Affairs. 41(10). 1423–1432. 55 indexed citations

11.

Gelinas, Luke, et al.. (2021). Navigating the ethics of remote research data collection. Clinical Trials. 18(5). 606–614. 8 indexed citations

12.

Meyer, Michelle N., Luke Gelinas, Barbara E. Bierer, et al.. (2021). An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials. 18(2). 226–233. 15 indexed citations

13.

Asch, David A., Steven Joffe, Barbara E. Bierer, et al.. (2020). Rethinking ethical oversight in the era of the learning health system. Healthcare. 8(4). 100462–100462. 8 indexed citations

14.

Gelinas, Luke, Sarah White, & Barbara E. Bierer. (2020). Economic vulnerability and payment for research participation. Clinical Trials. 17(3). 264–272. 24 indexed citations

15.

Bierer, Barbara E., et al.. (2020). Primed to comply: Individual participant data sharing statements on ClinicalTrials.gov. PLoS ONE. 15(2). e0226143–e0226143. 11 indexed citations

16.

White, Sarah, et al.. (2020). Promoting equity in understanding: A cross-organisational plain language glossary for clinical research. Medical Writing. 29. 10–15. 1 indexed citations

17.

Gelinas, Luke, Holly Fernandez Lynch, Emily A. Largent, et al.. (2018). Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials. Therapeutic Innovation & Regulatory Science. 52(3). 268–274. 2 indexed citations

18.

Balsari, Satchit, Suptendra Nath Sarbadhikari, Barbara E. Bierer, et al.. (2018). Reimagining Health Data Exchange: An Application Programming Interface–Enabled Roadmap for India. Journal of Medical Internet Research. 20(7). e10725–e10725. 32 indexed citations

19.

Lin, Huamao Mark, Maria Paola Martelli, & Barbara E. Bierer. (2001). The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. International Immunology. 13(1). 13–22. 10 indexed citations

20.

Bierer, Barbara E., Yasuyuki Takai, Julia Greenstein, et al.. (1987). Evidence that lfa 3 activates t cells via the cd2 receptor. Federation Proceedings. 46(4). 1498. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact